CPChetan Pundkar

Chetan Pundkar

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chetan Pundkar has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Amarjit Mishra

    Department of Pathobiology, College of Veterinary Medicine, Auburn University , Auburn, AL

    4 shared publications
  • Amol Suryawanshi

    Department of Population Health and Pathobiology, College of Veterinary Medicine, North Carolina State University, Raleigh, North Carolina, USA

    4 shared publications
  • Ferrin Antony

    Department of Pathobiology, College of Veterinary Medicine, Auburn University, Auburn, AL 36849, USA

    4 shared publications
  • Pengyu Chen

    Materials Research and Education Center, Materials Engineering, Department of Mechanical Engineering, Auburn University, Auburn, AL 36849, USA

    2 shared publications
  • Xuejia Kang

    Department of Drug Discovery and Development, Harrison College of Pharmacy, Auburn University, Auburn, AL 36849, USA

    2 shared publications
  • Anil Kumar Jaiswal

    Parasitology Division, CSIR-Central Drug Research Institute, Lucknow 226031, India

    1 shared publication

Latest Publications

  • Role of IL-27 in HSV-1–Induced Herpetic Stromal Keratitis

    by Ferrin Antony, Chetan Pundkar, Maninder Sandey, Amarjit Mishra, Amol Suryawanshi

    Herpetic stromal keratitis (HSK) is a painful and vision-impairing disease caused by recurrent HSV-1 infection of the cornea. The virus replication in the corneal epithelium and associated inflammation play a dominant role in HSK progression. Current HSK treatments targeting inflammation or virus replication are partially effective and promote HSV-1 latency, and long-term use can cause side effects. Thus, understanding molecular and cellular events that control HSV-1 replication and inflammation is crucial for developing novel HSK therapies. In this study, we report that ocular HSV-1 infection induces the expression of IL-27, a pleiotropic immunoregulatory cytokine. Our data indicate that HSV-1 infection stimulates IL-27 production by macrophages. Using a primary corneal HSV-1 infection mouse model and IL-27 receptor knockout mice, we show that IL-27 plays a critical role in controlling HSV-1 shedding from the cornea, the optimum induction of effector CD4+ T cell responses, and limiting HSK progression. Using in vitro bone marrow–derived macrophages, we show that IL-27 plays an antiviral role by regulating macrophage-mediated HSV-1 killing, IFN-β production, and IFN-stimulated gene expression after HSV-1 infection. Furthermore, we report that IL-27 is critical for macrophage survival, Ag uptake, and the expression of costimulatory molecules involved in the optimum induction of effector T cell responses. Our results indicate that IL-27 promotes endogenous antiviral and anti-inflammatory responses and represents a promising target for suppressing HSK progression.


  • Open Access

    Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity

    by Chetan Pundkar, Ferrin Antony, Xuejia Kang, Amarjit Mishra, R. Jayachandra Babu, Pengyu Chen, Feng Li, Amol Suryawanshi


  • Targeting β-catenin using XAV939 nanoparticle promotes immunogenic cell death and suppresses conjunctival melanoma progression

    by Ferrin Antony, Xuejia Kang, Chetan Pundkar, Chuanyu Wang, Amarjit Mishra, Pengyu Chen, R. Jayachandra Babu, Amol Suryawanshi


  • IFN-λ Regulates Neutrophil Biology to Suppress Inflammation in Herpes Simplex Virus-1–Induced Corneal Immunopathology

    by Ferrin Antony, Chetan Pundkar, Maninder Sandey, Anil K. Jaiswal, Amarjit Mishra, Ashok Kumar, Rudragouda Channappanavar, Amol Suryawanshi

    HSV-1 infection of the cornea causes a severe immunoinflammatory and vision-impairing condition called herpetic stromal keratitis (SK). The virus replication in corneal epithelium followed by neutrophil- and CD4+ T cell–mediated inflammation plays a dominant role in SK. Although previous studies demonstrate critical functions of type I IFNs (IFN-α/β) in HSV-1 infection, the role of recently discovered IFN-λ (type III IFN), specifically at the corneal mucosa, is poorly defined. Our study using a mouse model of SK pathogenesis shows that HSV-1 infection induces a robust IFN-λ response compared with type I IFN production at the corneal mucosal surface. However, the normal progression of SK indicates that the endogenous IFN responses are insufficient to suppress HSV-1–induced corneal pathology. Therefore, we examined the therapeutic efficacy of exogenous rIFN-λ during SK progression. Our results show that rIFN-λ therapy suppressed inflammatory cell infiltration in the cornea and significantly reduced the SK pathologic condition. Early rIFN-λ treatment significantly reduced neutrophil and macrophage infiltration, and IL-6, IL-1β, and CXCL-1 production in the cornea. Notably, the virucidal capacity of neutrophils and macrophages measured by reactive oxygen species generation was not affected. Similarly, ex vivo rIFN-λ treatment of HSV-1–stimulated bone marrow–derived neutrophils significantly promoted IFN-stimulated genes without affecting reactive oxygen species production. Collectively, our data demonstrate that exogenous topical rIFN-λ treatment during the development and progression of SK could represent a novel therapeutic approach to control HSV-1–induced inflammation and associated vision impairment. Key Points HSV-1 infection induces a strong IFN-λ response at the corneal epithelial surface. IFN-λ differentially regulates antiviral and inflammatory responses in the cornea. rIFN-λ treatment suppresses HSV-1–induced corneal immunopathology.